The influence of ACE inhibitors and ARBs on hospital length of stay and survival in people with COVID-19

OBJECTIVE: During the COVID-19 pandemic the continuation or cessation of angiotensin-converting enzyme inhibitors (ACEi) and angiotensin receptor blockers (ARBs) has been contentious. Mechanisms have been proposed for both beneficial and detrimental effects. Recent studies have focused on mortality...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Int J Cardiol Heart Vasc
Main Authors: Braude, Philip, Carter, Ben, Short, Roxanna, Vilches-Moraga, Arturo, Verduri, Alessia, Pearce, Lyndsay, Price, Angeline, Quinn, Terence J., Stechman, Michael, Collins, Jemima, Bruce, Eilidh, Einarsson, Alice, Rickard, Frances, Mitchell, Emma, Holloway, Mark, Hesford, James, Barlow-Pay, Fenella, Clini, Enrico, Myint, Phyo Kyaw, Moug, Susan, McCarthy, Kathryn, Hewitt, Jonathan
Formato: Artigo
Idioma:Inglês
Publicado: Elsevier 2020
Assuntos:
Original Paper
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7561344/
https://ncbi.nlm.nih.gov/pubmed/33083516
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijcha.2020.100660
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares